- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Optimer Pharmaceuticals Inc+ Add to Watchlist
OPTR:US14.6700 USD 0.2900 2.02%
As of 17:20:00 ET on 05/23/2013.
Company Profile for Optimer Pharmaceuticals Inc (OPTR)
Optimer Pharmaceuticals, Inc. discovers, develops, and commercializes anti infective products. Optimer's initial development efforts address products that treat gastrointestinal infections (GI), and related diseases, including diminished efficacy, serious adverse side effects, drug-to-drug interactions, difficult patient compliance, and bacterial resistance.
Optimer Pharmaceuticals Inc
Key Executives for Optimer Pharmaceuticals Inc (OPTR)
|Henry A McKinnell JrChairman/CEO||Stephen W WebsterChief Financial Officer|
|Eric SirotaChief Operating Officer||Meredith SchaumChief Compliance Ofcr/Gen Cnsl|
|Sherwood L GorbachSenior VP/Chief Scientific Ofcr||Linda E AmperSenior VP:Human Resources|
|David A WalseyVP:Investor Relations|